Ramachandra Sumant

Lyell Immunopharma, Inc. · Director

Ramachandra Sumant is listed in public filings as director. This Ramachandra Sumant insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Lyell Immunopharma, Inc. (LYEL). Investors use Ramachandra Sumant's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Trades

CompanyValueActionPriceCurrent Price
Lyell Immunopharma, Inc.LYEL$115k200k sharesBuyMar 21, 2025$0.5761--